Revelation Biosciences, Inc. SC 13G and SC 13G/A reports

Location
4660 Lajolla Village Drive, Suite 100, San Diego, CA
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
9/4/2024, 01:23 AM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report Feb 13, 2024
SC 13G Report REVB 13G 1.03.24 Jan 3, 2024
SC 13G Report Feb 21, 2023
SC 13G Report SCHEDULE 13G Feb 21, 2023
SC 13G Report SCHEDULE 13G Feb 14, 2023
SC 13G/A Report Feb 6, 2023
SC 13G/A Report SC 13G/A Jan 31, 2023
SC 13G/A Report AMENDMENT TO FORM SC 13G Aug 17, 2022
SC 13G Report SC 13G Mar 24, 2022
SC 13G/A Report KARPUS INVESTMENT MGT / REVELATION BIOSCIENCES - SCHEDULE 13G/A(#2) Mar 10, 2022
SC 13G/A Report Feb 14, 2022
SC 13G/A Report KARPUS INVESTMENT MGT / REVELATION BIOSCIENCES - SCHEDULE 13G/A(#1) Feb 14, 2022
SC 13G/A Report FORM SC 13G/A Feb 11, 2022
SC 13G Report Feb 9, 2022
SC 13G/A Report PAIC 13G/A Feb 4, 2022
SC 13G Report SC 13G Jan 20, 2022
SC 13G/A Report SCHEDULE 13G/A Jan 11, 2022
SC 13G/A Report Oct 12, 2021
SC 13G/A Report SCHEDULE 13G/A Oct 12, 2021
SC 13G Report SCHEDULE 13G Sep 28, 2021
SC 13G Report KARPUS INVESTMENT MGT / PETRA ACQUISITION - SCHEDULE 13G Aug 10, 2021
SC 13G/A Report Feb 16, 2021
SC 13G Report PAIC 13G Feb 10, 2021
SC 13G Report FORM SC 13G Feb 10, 2021
SC 13G/A Report SC 13G/A Feb 8, 2021
SC 13G/A Report Feb 5, 2021
SC 13G Report Nov 10, 2020
SC 13G Report Oct 16, 2020
SC 13G Report SC 13G Oct 16, 2020